Kevin Yee

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 856 citations · Full text

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

Kevin Yee, A O’Farrell, Beverly D. Smolich et al. · Blood · 2002 · 164 citations

Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD–positive leukemic cells

Kevin Yee, Marcus M. Schittenhelm, Anne-Marie O'Farrell et al. · Blood · 2004 · 120 citations · Full text

Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970

Amie S. Corbin, Ian J. Griswold, Paul La Rosée et al. · Blood · 2004 · 69 citations · Full text

Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit

Aviv Gazit, Kevin Yee, Andrea Uecker et al. · Bioorganic & Medicinal Chemistry · 2003 · 63 citations

Medicinal Chemistry, Pdgfr Kinase, Medicine +10